S&P 500   2,970.51 (+0.01%)
DOW   26,844.83 (+0.11%)
QQQ   191.39 (+0.15%)
AAPL   237.83 (+0.68%)
FB   184.35 (+0.09%)
MSFT   140.13 (+0.32%)
GOOGL   1,225.48 (+0.80%)
AMZN   1,729.40 (-0.15%)
CGC   18.29 (-5.87%)
NVDA   185.13 (-0.46%)
MU   44.93 (-0.40%)
BABA   172.03 (-0.53%)
AMD   29.63 (-0.40%)
T   37.64 (+0.16%)
F   8.81 (+0.34%)
ACB   3.41 (-7.60%)
NFLX   283.87 (+0.33%)
BAC   29.03 (+0.42%)
GILD   64.35 (+0.56%)
DIS   130.00 (-0.02%)
S&P 500   2,970.51 (+0.01%)
DOW   26,844.83 (+0.11%)
QQQ   191.39 (+0.15%)
AAPL   237.83 (+0.68%)
FB   184.35 (+0.09%)
MSFT   140.13 (+0.32%)
GOOGL   1,225.48 (+0.80%)
AMZN   1,729.40 (-0.15%)
CGC   18.29 (-5.87%)
NVDA   185.13 (-0.46%)
MU   44.93 (-0.40%)
BABA   172.03 (-0.53%)
AMD   29.63 (-0.40%)
T   37.64 (+0.16%)
F   8.81 (+0.34%)
ACB   3.41 (-7.60%)
NFLX   283.87 (+0.33%)
BAC   29.03 (+0.42%)
GILD   64.35 (+0.56%)
DIS   130.00 (-0.02%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 Corcept TherapeuticsPacira BiosciencesAlder BiopharmaceuticalsHeron TherapeuticsMadrigal Pharmaceuticals
SymbolNASDAQ:CORTNASDAQ:PCRXNASDAQ:ALDRNASDAQ:HRTXNASDAQ:MDGL
Price Information
Current Price$13.83$36.76$18.87$17.80$86.17
52 Week RangeBuyBuyHoldBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyBuy
Consensus Price Target$15.75$55.67$18.44$50.57$177.00
% Upside from Price Target13.88% upside51.43% upside-2.29% downside184.11% upside105.41% upside
Trade Information
Market Cap$1.60 billion$1.53 billion$1.58 billion$1.43 billion$1.33 billion
Beta1.391.112.641.421.09
Average Volume751,6391,268,4577,118,1981,490,412203,464
Sales & Book Value
Annual Revenue$251.25 million$337.28 million$1.62 million$77.47 millionN/A
Price / Sales6.264.54976.5818.34N/A
Cashflow$0.65 per share$0.96 per shareN/AN/AN/A
Price / Cash21.3138.47N/AN/AN/A
Book Value$2.39 per share$7.81 per share$1.61 per share$4.74 per share$30.99 per share
Price / Book5.794.7111.723.76N/A
Profitability
Net Income$75.41 million$-470,000.00$-296,430,000.00$-178,840,000.00$-32,810,000.00
EPS$0.60$0.29($4.87)($2.44)($2.22)
Trailing P/E Ratio23.05126.76N/AN/AN/A
Forward P/E Ratio14.5628.06N/AN/AN/A
P/E GrowthN/A$1.69N/AN/AN/A
Net Margins29.16%2.04%N/A-172.07%N/A
Return on Equity (ROE)27.97%8.62%-226.13%-56.89%-11.62%
Return on Assets (ROA)24.84%3.90%-66.86%-45.19%-11.38%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.99%1.74%0.04%N/A
Current Ratio7.66%4.75%8.94%4.01%38.06%
Quick Ratio7.49%4.12%8.94%3.70%38.06%
Ownership Information
Institutional Ownership Percentage75.17%99.10%N/AN/A61.78%
Insider Ownership Percentage15.50%5.80%15.40%12.56%47.69%
Miscellaneous
Employees16651820219817
Shares Outstanding113.69 million41.63 million83.84 million79.82 million15.43 million
Next Earnings Date11/7/2019 (Estimated)11/7/2019 (Estimated)11/4/2019 (Estimated)11/6/2019 (Estimated)11/5/2019 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable
 Corcept TherapeuticsPacira BiosciencesAlder BiopharmaceuticalsHeron TherapeuticsMadrigal Pharmaceuticals

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel